(CLEM) Clemondo (publ) - Ratings and Ratios

Clemondo Group AB (publ) is a Swedish company that specializes in developing, manufacturing, and distributing a diverse array of hygiene and cleaning products catering to the automotive, healthcare, and industrial sectors. The companys product portfolio includes hand disinfection, soap, and hand cream, as well as hygiene solutions such as shampoo, conditioner, and body soap. Additionally, Clemondo offers disinfection solutions in various forms like sprays, agents, and wipes, and surface cleaning solutions. The company also provides training and screening services, enhancing its value proposition beyond mere product sales. Clemondos products are marketed under well-established brands including Lahega, Liv, and Strovels, indicating a strong brand presence in its operating markets.

With a history dating back to 1952 and headquartered in Helsingborg, Sweden, Clemondo Group AB (publ) has evolved significantly over the years, including a name change from NC Lahega AB (publ) to its current name in May 2017. This rebranding reflects the companys strategic efforts to reposition itself in the market. The companys commitment to hygiene and cleaning solutions positions it favorably in sectors where cleanliness and hygiene are paramount.

Analyzing the provided technical data, Clemondos stock (CLEM) is currently priced at 10.20 SEK, showing a positive trend as it is above its SMA20 (9.47 SEK), SMA50 (8.63 SEK), and SMA200 (7.95 SEK). The Average True Range (ATR) stands at 0.48, equivalent to 4.66% of the current price, indicating moderate volatility. The stock is near its 52-week high of 10.50 SEK, suggesting strong recent performance. Considering the fundamental data, the company has a market capitalization of 142.62M SEK, a P/E ratio of 22.89, and a forward P/E of 10.21, indicating potential for growth as the forward P/E is significantly lower than the current P/E. The Return on Equity (RoE) is 5.43%, a modest figure that could be improved upon.

Forecasting Clemondos stock performance based on the available technical and fundamental data, the upward trend indicated by the stock being above its various SMAs is a positive sign. The relatively moderate volatility, as indicated by the ATR, suggests that the stock is not excessively risky. The significant difference between the current and forward P/E ratios suggests that the market expects earnings to increase, potentially driving the stock price up. Therefore, if Clemondo can maintain or improve its current operational performance, particularly in enhancing its RoE, the stock could see further gains, potentially reaching or surpassing its 52-week high in the near term. Investors should closely monitor the companys future earnings reports and industry trends to gauge the potential for sustained growth.